Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: how AI might be implemented in the diagnosis and care of metastatic breast cancer
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: why staying current with technology is critical in oncology
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: the future of personalized ovarian response prediction
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy
Dx dialogues: other potential treatments for indolent systemic mastocytosis
An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.
Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.
While much of your cancer risk is out of your hands, you may be able to lower your odds by managing your weight.
An overview of hospice care, including the benefits it can offer and basic strategies for finding hospice care.
Why red blood cells are so important, and how these cells are affected by sickle cell disease.